Identification of genomic copy number variations associated with specific clinical features of head and neck cancer

• Published in: Molecular cytogenetics Vol. 11; no. 1; p. 5
• Main Authors: Zagradišnik, Boris, Krgović, Danijela, Herodež, Špela Stangler, Zagorac, Andreja, Ćižmarević, Bogdan, Vokač, Nadja Kokalj
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 15-01-2018; BioMed Central; BMC
• Subjects: Array comparative genomic hybridization; Biomarkers; Comparative analysis; Copy number variations; Cytogenetics; Development and progression; Genetic aspects; Genetic variation; Head and neck cancer; Physiological aspects; Slovenia; Biomarkers; Head and neck cancer; Array comparative genomic hybridization; Copy number variations
• ISSN: 1755-8166; 1755-8166
• DOI: 10.1186/s13039-018-0354-8

Copy number variations (CNSs) of large genomic regions are an important mechanism implicated in the development of head and neck cancer, however, for most changes their exact role is not well understood. The aim of this study was to find possible associations between gains/losses of genomic regions and clinically distinct subgroups of head and neck cancer patients.
Array comparative genomic hybridization (aCGH) analysis was performed on DNA samples in 64 patients with cancer in oral cavity, oropharynx or hypopharynx. Overlapping genomic regions created from gains and losses were used for statistical analysis. Following regions were overrepresented: in tumors with stage I or II a gain of 2.98 Mb on 6p21.2-p11 and a gain of 7.4 Mb on 8q11.1-q11.23; in tumors with grade I histology a gain of 1.1 Mb on 8q24.13, a loss of a large part of p arm of chromosome 3, a loss of a 1.24 Mb on 6q14.3, and a loss of terminal 32 Mb region of 8p23.3; in cases with affected lymph nodes a gain of 0.75 Mb on 3q24, and a gain of 0.9 Mb on 3q26.32-q26.33; in cases with unaffected lymph nodes a gain of 1.1 Mb on 8q23.3, in patients not treated with surgery a gain of 12.2 Mb on 7q21.3-q22.3 and a gain of 0.33 Mb on 20q11.22.
Our study identified several genomic regions of interest which appear to be associated with various clinically distinct subgroups of head and neck cancer. They represent a potentially important source of biomarkers useful for the clinical management of head and neck cancer. In particular, the
and
genes could be singled out to predict the lymph node involvement.